CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma

Biochemical and Biophysical Research Communications

Volumn 447, Issue 2, 2014, Pages 304-310

  Zhang, Heyu ^a   Nan, Xu ^b   Li, Xuefen ^a   Chen, Yan ^a   Zhang, Jianyun ^a   Sun, Lisha ^a   Han, Wenlin ^b   Li, Tiejun ^a  

^a PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

CMTM5; Oral squamous cell carcinoma; Promoter methylation; Tumor suppressor

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CKLF LIKE MARVEL TRANSMEMBRANE DOMAIN CONTAINING MEMBER 5; MARVEL DOMAIN CONTAINING PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; METHYLATION; MOUSE; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TUMOR SUPPRESSOR GENE;

CMTM5; ORAL SQUAMOUS CELL CARCINOMA; PROMOTER METHYLATION; TUMOR SUPPRESSOR;

ADULT; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHEMOKINES; DNA METHYLATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MARVEL DOMAIN-CONTAINING PROTEINS; MIDDLE AGED; MOUTH NEOPLASMS; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 84899952272     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.03.158     Document Type: Article

References (24)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics CA Cancer J. Clin. 63 2013 2013 11 30
2. A. Saulnier, T. Vaissiere, J. Yue, M. Siouda, M. Malfroy, R. Accardi, M. Creveaux, S. Sebastian, N. Shahzad, T. Gheit, I. Hussain, M. Torrente, F.A. Maffini, L. Calabrese, F. Chiesa, C. Cuenin, R. Shukla, I. Fathallah, E. Matos, A. Daudt, S. Koifman, V. Wunsch-Filho, A.M. Menezes, M.P. Curado, D. Zaridze, P. Boffetta, P. Brennan, M. Tommasino, Z. Herceg, and B.S. Sylla Inactivation of the putative suppressor gene DOK1 by promoter hypermethylation in primary human cancers Int. J. Cancer 130 2011 2484 2494
3. P.A. Jones, and S.B. Baylin The fundamental role of epigenetic events in cancer Nat. Rev. Genet. 3 2002 415 428
4. S.B. Baylin, and J.E. Ohm Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer 6 2006 107 116
5. W. Han, P. Ding, M. Xu, L. Wang, M. Rui, S. Shi, Y. Liu, Y. Zheng, Y. Chen, T. Yang, and D. Ma Identification of eight genes encoding chemokine-like factor superfamily members 1-8 (CKLFSF1-8) by in silico cloning and experimental validation Genomics 81 2003 609 617
6. W. Han, Y. Lou, J. Tang, Y. Zhang, Y. Chen, Y. Li, W. Gu, J. Huang, L. Gui, Y. Tang, F. Li, Q. Song, C. Di, L. Wang, Q. Shi, R. Sun, D. Xia, M. Rui, J. Tang, and D. Ma Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity Biochem. J. 357 2001 127 135
7. H. Li, X. Guo, L. Shao, M. Plate, X. Mo, Y. Wang, and W. Han CMTM5-v1, a four-transmembrane protein, presents a secreted form released via a vesicle-mediated secretory pathway BMB Rep. 43 2010 182 187
8. P. Li, K. Liu, L. Li, M. Yang, W. Gao, J. Feng, Y. Lv, X. Qu, and B. Kong Reduced CMTM5 expression correlates with carcinogenesis in human epithelial ovarian cancer Int. J. Gynecol. Cancer. 21 2011 1248 1255
9. X. Guo, T. Li, Y. Wang, L. Shao, Y. Zhang, D. Ma, and W. Han CMTM5 induces apoptosis of pancreatic cancer cells and has synergistic effects with TNF-alpha Biochem. Biophys. Res. Commun. 387 2009 139 142
10. J. Niu, H. Li, Y. Zhang, J. Li, M. Xie, L. Li, X. Qin, Y. Qin, X. Guo, Q. Jiang, Y. Liu, S. Chen, X. Huang, W. Han, and G. Ruan Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia Leuk. Res. 35 2011 771 776
11. L. Shao, Y. Cui, H. Li, Y. Liu, H. Zhao, Y. Wang, Y. Zhang, K.M. Ng, W. Han, D. Ma, and Q. Tao CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines Clin. Cancer Res. 13 2007 5756 5762
12. L. Shao, X. Guo, M. Plate, T. Li, Y. Wang, D. Ma, and W. Han CMTM5-v1 induces apoptosis in cervical carcinoma cells Biochem. Biophys. Res. Commun. 379 2009 866 871
13. H. Zhang, X. Ma, T. Shi, Q. Song, H. Zhao, and D. Ma NSA2, a novel nucleolus protein regulates cell proliferation and cell cycle Biochem. Biophys. Res. Commun. 391 2009 651 658
14. A. Mutirangura, W. Pornthanakasem, V. Sriuranpong, P. Supiyaphun, and N. Voravud Loss of heterozygosity on chromosome 14 in nasopharyngeal carcinoma Int. J. Cancer 78 1998 153 156
15. M. Koike, A.M. Chumakov, S. Takeuchi, T. Tasaka, R. Yang, T. Nakamaki, N. Tsuruoka, and H.P. Koeffler C/EBP-epsilon: chromosomal mapping and mutational analysis of the gene in leukemia and preleukemia Leuk. Res. 21 1997 833 839
16. M. Tepel, P. Roerig, M. Wolter, D.H. Gutmann, A. Perry, G. Reifenberger, and M.J. Riemenschneider Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma Int. J. Cancer 123 2008 2080 2086
17. E.A. Lusis, M.A. Watson, M.R. Chicoine, M. Lyman, P. Roerig, G. Reifenberger, D.H. Gutmann, and A. Perry Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma Cancer Res. 65 2005 7121 7126
18. H. Uesugi, K. Uzawa, K. Kawasaki, K. Shimada, T. Moriya, A. Tada, M. Shiiba, and H. Tanzawa Status of reduced expression and hypermethylation of the APC tumor suppressor gene in human oral squamous cell carcinoma Int. J. Mol. Med. 15 2005 597 602
19. P.F. Su, W.L. Huang, H.T. Wu, C.H. Wu, T.Y. Liu, and S.Y. Kao P16(INK4A) promoter hypermethylation is associated with invasiveness and prognosis of oral squamous cell carcinoma in an age-dependent manner Oral Oncol. 46 2010 734 739
20. E. Ishida, M. Nakamura, M. Ikuta, K. Shimada, S. Matsuyoshi, T. Kirita, and N. Konishi Promotor hypermethylation of p14ARF is a key alteration for progression of oral squamous cell carcinoma Oral Oncol. 41 2005 614 622
21. J.A. Gasche, and A. Goel Epigenetic mechanisms in oral carcinogenesis Future Oncol. 8 2012 1407 1425
22. S. Sarkar, S. Goldgar, S. Byler, S. Rosenthal, and S. Heerboth Demethylation and re-expression of epigenetically silenced tumor suppressor genes: sensitization of cancer cells by combination therapy Epigenomics 5 2013 87 94
23. C. Balch, P. Yan, T. Craft, S. Young, D.G. Skalnik, T.H. Huang, and K.P. Nephew Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer Mol. Cancer Ther. 4 2005 1505 1514
24. S. Hagemann, O. Heil, F. Lyko, and B. Brueckner Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines PLoS One 6 2011 e17388